{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-189169","form_type":"8-K","ticker":"VOR","cik":"0001817229","company_name":"Vor Biopharma Inc.","filed_at":"2025-08-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.100594+00:00","generated_at":"2026-05-17T09:45:53.254395+00:00","sec_items":["5.02","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Vor Biopharma stockholders approve reverse stock split, equity plan amendment; files $119.7M ATM prospectus","bullets":["Stockholders approved reverse stock split in range 1-for-5 to 1-for-30; board to determine ratio.","Approved amendment to 2021 equity plan to add 25M shares and reduce annual evergreen from 5% to 4%.","Approved issuance of common stock underlying outstanding warrants for Nasdaq Listing Rule 5635(d) compliance.","Filed prospectus supplement to register up to $119.7M of common stock for ATM offering through Stifel."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-189169","json":"https://secwatch.observer/filing/0001193125-25-189169.json","markdown":"https://secwatch.observer/filing/0001193125-25-189169.md","text":"https://secwatch.observer/filing/0001193125-25-189169.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817229/000119312525189169/0001193125-25-189169-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817229/000119312525189169/d24419d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T09:45:53.254395+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}